Clinical Trials Logo

Filter by:
NCT ID: NCT01822236 Completed - Low Back Pain Clinical Trials

Craniosacral Therapy to Treat Chronic Low Back Pain

Start date: April 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether a craniosacral therapy program are effective on disability, quality of life, autonomic nervous system and oxidative stress indicators in patients with chronic low back pain.

NCT ID: NCT01822184 Completed - Hunter Syndrome Clinical Trials

Observational Study to Evaluate Neurodevelopmental Status in Pediatric Patients With Hunter Syndrome (MPS II)

Start date: January 18, 2013
Phase:
Study type: Observational

Hunter syndrome (Mucopolysaccharidosis II, [MPS II]) is a rare, genetically linked lysosomal storage disease (LSD) caused by deficiency of the enzyme, iduronate-2-sulfatase (I2S). Most MPS II patients will present with some degree of neurodevelopmental involvement, ranging from severe cognitive impairment and behavioral problems to mildly impaired cognition. This is an observational study; no investigational treatment will be administered. The primary objective of this study is to evaluate the neurodevelopmental status of pediatric patients with MPS II over time and to gain information to guide future treatment studies in this patient population.

NCT ID: NCT01821885 Completed - COPD Clinical Trials

Effectiveness of Spirometry as a Motivational Tool to Quit Smoking

ESPIMOAT
Start date: April 2012
Phase: N/A
Study type: Interventional

The aim of the study is to asses the efficacy of the spirometry and a minimal smoking cessation counselling intervention to quit smoking after a year in patients older than 40 years, smokers of more than 10 packs-year and without a chronic obstructive pulmonary disease (COPD) diagnosis.

NCT ID: NCT01821716 Completed - Allergic Rhinitis Clinical Trials

Biological Standardization of Dermatophagoides Pteronyssinus Allergen Extract

Start date: March 2013
Phase: Phase 2
Study type: Interventional

The objective of this study is to determine the biologic activity of a Dermatophagoides pteronyssinus allergen extract in histamine equivalent prick (HEP) units, in order to be used as in-house reference preparation (IHRP).

NCT ID: NCT01821391 Completed - Actinic Keratoses Clinical Trials

Phase 3b Study of Metvix NDL-PDT Versus Metvix c-PDT in Subjects With Actinic Keratoses

COMET2
Start date: July 2013
Phase: Phase 3
Study type: Interventional

This study was to be conducted as a multi-centre, randomized, investigator-blinded, active and vehicle-controlled, intra-individual (split-face/scalp) non-inferiority (regarding efficacy) and superiority (regarding pain) study. The primary purpose of this study is to demonstrate the non-inferiority of NDL-PDT compared to c-PDT in terms of lesion complete response rate.

NCT ID: NCT01820767 Completed - Clinical trials for Chronic Kidney Disease

Paricalcitol Over Inflammatory Parameters on Chronical Kidney Disease Patients

SENPARIC
Start date: August 2012
Phase: Phase 3
Study type: Interventional

Use of Paricalcitol in stage Vd Chronic Kidney Disease patients, over the effect of inflammatory and oxidative stress parameters.

NCT ID: NCT01820611 Completed - Clinical trials for Rheumatoid Arthritis

Arcos Revision Stem: Evaluation of Clinical Performance

Start date: February 2013
Phase:
Study type: Observational

The primary purpose of this study is to evaluate the clinical performance of the Arcos Revision Stem system, determine the stability of the implants, and evaluate any relationship between Paprosky bone defect level and the success of the Arcos Stem.

NCT ID: NCT01820364 Completed - Melanoma Clinical Trials

LGX818 in Combination With Agents (MEK162; BKM120; LEE011; BGJ398; INC280) in Advanced BRAF Melanoma

LOGIC
Start date: November 2013
Phase: Phase 2
Study type: Interventional

The primary purpose of the Phase II CLGX818X2102 study is to assess the anti-tumor activity of LGX818 in combination with selected agents.

NCT ID: NCT01820156 Completed - Clinical trials for Obstructive Sleep Apnea Syndrome

Diagnosis of Patients With Low or Intermediate Suspicion of SAHS or With Comorbidity: Standard Laboratory Polysomnography Compared With Three Nights of Home Respiratory Polygraphy.

Start date: February 2012
Phase: N/A
Study type: Interventional

Study Objectives: Obstructive sleep apnea (OSA) diagnosis using simplified methods such as home respiratory polygraphy (HRP) is only recommended in patients with a high pre-test probability. The aim is to determine the diagnostic efficacy, therapeutic decision-making and costs of OSA diagnosis using PSG or three consecutive studies of HRP in patients with mild-moderate suspicion of sleep apnea or with co-morbidity that can mask OSA symptoms. Design and Setting: Randomized, blinded, crossover study of three nights of HRP (3N-HRP) vs. PSG. The diagnostic efficacy was evaluated with ROC curves. Therapeutic decisions to assess concordance between the two different approaches were analyzed by sleep physicians and respiratory physicians (staff and residents) using agreement level and kappa coefficient. The costs of each diagnostic strategy were considered.

NCT ID: NCT01819948 Completed - Breast Cancer Clinical Trials

Changes in Biomarkers of Cancer in Women With Breast Cancer and Without Evidence of Disease Who Were Given PhytoMed™

Start date: June 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether the administration of the PhytoMed™ complement reduces CRP in women with histologically confirmed AJCC Stage 0-IIIA breast cancer which has been completely surgically resected and without evidence of disease as determined by their physician